Clinical Trials · NCT06592261

Graded Insulin Suppression Test P&F

Phase
Phase 1
Recruitment status
Recruiting
Sponsor
Columbia University
Enrollment
15
Start date
Sep 2024
Locations
1 site, United States
Primary endpoint
Steady-state plasma glucose at euinsulinemia (ESS-G)
View Octreotide compound reference